Clinical Trial Update: Interleukin-2 on Active Dermatomyositis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating interleukin-2 for active dermatomyositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Dermatomyositis | Phase 3 | Status: ENROLLING_BY_INVITATION